Sage Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Sage Capital Management's IBB Position: Q3 2026 in Review
Sage Capital Management increased its iShares Biotechnology ETF (IBB) stake by 9.1% in Q3 2026, buying an estimated $199K and bringing the position to 11,913 shares worth $2.51M. The position accounts for 0.95% of the portfolio, ranked #31.
Sage Capital Management first reported a position in IBB in Q2 2026 and has held it in 2 quarters since. 1,019 funds tracked by Wall St. Rank hold IBB as of Q3 2026.
- Sage Capital Management held 11,913 shares of iShares Biotechnology ETF worth $2.51M as of Q3 2026.
- Sage Capital Management bought 990 iShares Biotechnology ETF shares in Q3 2026, an estimated $199K.
- iShares Biotechnology ETF made up 0.95% of Sage Capital Management's portfolio in Q3 2026, its #31 holding.
- Sage Capital Management first reported a position in iShares Biotechnology ETF in Q2 2026 and has held it in 2 quarters since.
- 1,019 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.
Based on Sage Capital Management's 13F filing for Q3 2026, filed 20 Oct 2026.